K.K. CYBO
Latest round
- Series A
Last raised
- Jun 2023
Total raised
- $3.4M
Investors
- 2
About K.K. CYBO
K. CYBO manufactures and sells scientific instruments, software for research, reagents, and consumable goods. It also plans, designs, manufactures, and sells medical goods. It has jointly developed cell measurement equipment.K. CYBO has accepted research and development tasks. The company has also implemented, used, maintained, and managed intellectual property rights.K.K. CYBO carries out the development of scientific instruments, medical instruments and software in order to "know the cell deeply, and to use it widely". Its skill is technical development that makes use of high-speed imaging, which is its foundation technology, real-time AI, and high-speed manufacturing control. It develops ENMA, which is an innovative image cell sorter that analyzes cell images by AI and isolates them, and SHIGI, a cell scanner that analyzes cells in real-time AI using high-speed 3D images. It also develops ENMA, which is an innovative image cell sorter that analyzes cell images by AI and isolates them, and SHIGI, a cell scanner that analyzes cells in real-time AI using high-speed 3D images.
Who invested in K.K. CYBO
2 investors across 2 rounds
See all investors in K.K. CYBO
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about K.K. CYBO
Who invested in K.K. CYBO?
K.K. CYBO has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has K.K. CYBO raised?
K.K. CYBO has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did K.K. CYBO last raise money?
K.K. CYBO's most recent round on record is a Series A, in Jun 2023.
What does K.K. CYBO do?
K.K. CYBO is a biotechnology company.
Where is K.K. CYBO headquartered?
K.K. CYBO is headquartered in Tokyo, Japan.
Which VCs invest in companies like K.K. CYBO?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at K.K. CYBO's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like K.K. CYBO? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.